Change in NAV (N/A)
Since previous NAV (N/A)
Recommended Holding Period
Risk and Reward Profile
The Fund’s investment strategy is designed to maximize value creation to its Investors leveraging on its Management Team’s expertise across a broad range of sectors, long experience in the fields of innovations in biotech and longevity. To achieve its strategic goals, the Fund intends to have a stake in the future high-growth longevity businesses by supporting them early.
Inception Date (Fund):
08/04/2021
Legal form:
RAIF
Benchmark:
N/A
Currency (Fund):
EUR
Distribution Policy:
Reinvesting
Valuation frequency:
Quarterly
Minimum initial investment:
EUR 125,000
ISIN Code:
CYF000001877
AuM (Fund):
N/A
Regulatory authority:
CySEC
Management company:
7Q Asset Management Ltd
Delegated Management Company:
N/A
Incorporation:
Cyprus
Management fee:
2.5%
Subscription and redemption conditions:
Quarterly before 12.30 am C.E.T. on day’s net asset value
Subscription fee:
N/A
Performance fee:
20% of the increase in the NAV of the Fund above a hurdle rate of 7%, subject to high water mark